Bioactive Molecule-loaded Drug Delivery Systems to Optimize Bone Tissue Repair

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Bioactive peptides and proteins are crucial for bone tissue repair but have short half-lives and instability when used alone.
• Drug delivery systems (DDS) are being intensely researched to overcome these limitations and optimize bone regeneration.
• DDS physicochemical properties enhance cellular interactions and enable sustained release of therapeutic molecules.

Purpose of the Study:

• To review drug delivery systems (DDS) loaded with osteogenic growth peptide and bone morphogenetic protein for bone tissue repair.
• To present various DDS approaches for bone regeneration, including membranes, scaffolds, grafts, cements, liposomes, and micelles.
• To compare the advantages of these DDS with existing commercial systems.

Main Methods:

• Literature review of DDS for bone tissue engineering.
• Focus on DDS incorporating osteogenic growth peptide and bone morphogenetic protein.
• Analysis of different DDS formulations and their applications in bone regeneration.

Main Results:

• DDS improve the stability and bioavailability of bioactive molecules for bone repair.
• Various DDS platforms (scaffolds, liposomes, etc.) demonstrate potential for enhanced bone regeneration.
• Sustained release from DDS optimizes cellular responses, favoring bone homeostasis.

Conclusions:

• Bioactive molecule-loaded DDS are essential for effective bone tissue repair and regeneration.
• Different DDS approaches offer unique advantages for therapeutic delivery and clinical application.
• Further development and comparison with commercial systems are needed to optimize therapeutic outcomes.